Olanzapine presents a half-life ranging between 21 to 54 hours with an average half-life of 30 hours
: Olanzapine long- acting injection is not licensed for use in those less than 18 years of age
Its mean half-life in healthy individuals was 33 hours, ranging from 21 to 54 hours
acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder
What is this medication? OLANZAPINE (oh LAN za peen) treats symptoms of schizophrenia and bipolar disorder
ZyPREXA; ZyPREXA Zydis; Descriptions
Generic name: olanzapine (oral) [ oh-LANZ-a-peen ] Brand names: ZyPREXA, ZyPREXA Zydis
Olanzapine also comes as an injectable solution given only by a healthcare professional
This is so your progress can be checked
Olanzapine can also be administered as an injection given by a professional, once every 2 to 4 weeks
Olanzapine is in a class of medications called atypical antipsychotics
It's taken by mouth or
Zyprexa (Olanzapine (Injection)) Generic Name: Olanzapine (oral) Olanzapine is an antipsychotic medication that is used to treat psychotic conditions such as schizophrenia and bipolar disorder increased blinking or spasms of the eyelid
loss of memory
Children younger than 10 years of age—Use and dose must be determined by your doctor
Symptoms include confusion, fever The pharmacokinetics of olanzapine are linear and dose-proportional within the approved dosage range
Some of olanzapine’s most common side effects are drowsiness, constipation, and dry mouth
Initially 300 mg every 2 weeks, then maintenance 210 mg every 2 weeks, alternatively maintenance 405 mg every 4 weeks, maintenance dose to be started after 2 months of Half-life was ∼30 days, controlled by the slow rate of intramuscular absorption rather than the 30-h elimination rate-based half-life of oral olanzapine
Prices Medicare Drug Info Side Effects Images Olanzapine ( Zyprexa , Zyprexa Zydis ) is a moderately priced drug used to treat schizophrenia , psychotic disorders, and bipolar disorder
depression, psychomotor impairment, severe hypotension (incl
Each vial provides for the administration of 10 mg (32 μmol) olanzapine with inactive ingredients 50 mg lactose monohydrate and 3
difficulty swallowing
Olanzapine injection and olanzapine extended-release injection may cause other side effects
large, flat, blue, or purplish patches in the skin
Once the drug is absorbed from the injection site into the bloodstream, the distribution and elimination of LAI antipsychotics is the same as after oral dosing
105 The association between olanzapine half-life